Breathing looks simple from the outside: inhale, exhale, repeat. Behind the scenes, however, the heart and lungs are running a tightly coordinated delivery service. Blood travels from the right side of the heart through the pulmonary blood vessels, collects oxygen in the lungs, and returns to the left side of the heart for distribution throughout the body.
Pulmonary vascular disease can disrupt that system. The term describes a broad family of conditions affecting the arteries, veins, and smaller blood vessels that carry blood through the lungs. These conditions may narrow, block, scar, inflame, or otherwise damage the vessels. As resistance to blood flow rises, the right side of the heart must pump harderessentially being asked to push traffic through a road that keeps losing lanes.
Pulmonary hypertension is one of the most important forms or consequences of pulmonary vascular disease, but the two terms are not identical. Pulmonary vascular disorders also include pulmonary embolism, chronic thromboembolic disease, pulmonary vein disorders, pulmonary arteriovenous malformations, and several rare conditions. Understanding the exact type matters because treatments that help one form may be ineffectiveor even harmfulfor another.
Evidence basis: NHLBI, CDC, and Johns Hopkins Medicine.
What Is Pulmonary Vascular Disease?
Pulmonary vascular disease affects the circulation between the heart and lungs. Normally, blood pressure within the pulmonary circulation is much lower than the blood pressure measured with a cuff on your arm. The vessels are designed to accept blood from the right ventricle and move it efficiently through the lungs.
If pulmonary arteries become stiff, thickened, narrowed, or blocked, the heart must generate more pressure to maintain blood flow. Over time, this extra workload can enlarge and weaken the right ventricle. Eventually, the heart may struggle to deliver enough blood and oxygen to the rest of the body.
Pulmonary hypertension is currently defined by a mean pulmonary artery pressure greater than 20 millimeters of mercury at rest, measured during right heart catheterization. That number alone does not reveal the cause. Doctors must also evaluate pressures on the left side of the heart, pulmonary vascular resistance, lung function, imaging findings, and the patient’s medical history.
Evidence basis: American Heart Association, Merck Manual, and American College of Cardiology.
Common Symptoms of Pulmonary Vascular Disease
Symptoms often develop gradually, especially in chronic pulmonary hypertension. Because early signs resemble asthma, anemia, deconditioning, heart disease, anxiety, and ordinary exhaustion, diagnosis may be delayed. “I get winded on stairs” does not immediately announce which organ system is responsible.
Shortness of Breath During Activity
Breathlessness with exertion is one of the most common symptoms. At first, it may occur only during strenuous exercise. As the condition progresses, walking across a parking lot, carrying groceries, showering, or getting dressed may become difficult.
Unusual Fatigue
When the heart cannot increase blood flow effectively during activity, the muscles receive less oxygen-rich blood. A person may feel profoundly tired even after adequate sleep. This fatigue is often described as a lack of physical power rather than ordinary sleepiness.
Chest Pressure or Pain
Chest discomfort may develop when the right ventricle is working hard or when blood flow through the pulmonary circulation is severely restricted. New or unexplained chest pain should always be medically evaluated rather than blamed on indigestion, stress, or an especially ambitious dinner.
Dizziness, Lightheadedness, or Fainting
During exertion, the heart may be unable to increase its output enough to supply the brain. This can cause lightheadedness or fainting, particularly during exercise. Fainting with activity is a potentially serious warning sign.
Palpitations
Some people notice a racing, pounding, or irregular heartbeat. Pulmonary vascular disease can place strain on the heart and increase the risk of abnormal heart rhythms.
Swelling and Fluid Retention
When right-sided heart function declines, fluid may accumulate in the ankles, feet, legs, or abdomen. People may notice tighter shoes, rapidly changing body weight, abdominal fullness, or reduced appetite.
Additional Symptoms
Other possible signs include bluish or grayish lips and fingertips, coughing, wheezing, weakness, reduced appetite, upper-right abdominal discomfort, and difficulty keeping up with normal activities.
Evidence basis: CDC, Cleveland Clinic, American Heart Association, and MedlinePlus.
When Symptoms Require Emergency Care
Call 911 for sudden severe shortness of breath, unexplained chest pain, fainting, coughing up blood, a very fast heartbeat, confusion, bluish skin, or symptoms accompanied by extremely low blood pressure. These may indicate an acute pulmonary embolism, severe oxygen deprivation, or heart failure.
An acute pulmonary embolism occurs when a clotoften originating in a deep vein of the legtravels to the lungs and blocks an artery. Unlike slowly progressive pulmonary hypertension, symptoms can appear abruptly and may become life-threatening within minutes or hours.
Evidence basis: CDC and NHLBI guidance on pulmonary embolism.
What Causes Pulmonary Vascular Disease?
There is no single cause. Pulmonary hypertension is divided into five major groups according to the underlying mechanism. This classification is more than medical filing: it determines which treatment strategy makes sense.
Group 1: Pulmonary Arterial Hypertension
Pulmonary arterial hypertension, or PAH, develops when small pulmonary arteries become narrowed, thickened, and stiff. It may be idiopathic, meaning no cause is identified, or hereditary because of a gene variant.
PAH may also be associated with connective tissue diseases such as systemic sclerosis or lupus, congenital heart disease, portal hypertension related to liver disease, HIV infection, schistosomiasis, and certain medications or drugs. Pulmonary veno-occlusive disease is a rare related disorder involving small veins and capillaries.
Group 2: Pulmonary Hypertension Caused by Left Heart Disease
This is the most common form of pulmonary hypertension in the United States. It can result from heart failure, mitral or aortic valve disease, cardiomyopathy, or impaired relaxation of the left ventricle.
When pressure builds on the left side of the heart, it can back up into the pulmonary veins and lungs. The primary treatment is management of the underlying heart conditionnot automatically prescribing PAH-specific medication.
Group 3: Pulmonary Hypertension Caused by Lung Disease or Low Oxygen
Chronic obstructive pulmonary disease, emphysema, interstitial lung disease, pulmonary fibrosis, sleep-related breathing disorders, and long-term exposure to low-oxygen environments can raise pressure in the pulmonary circulation.
Chronic low oxygen causes pulmonary vessels to constrict. Lung scarring may also destroy portions of the vascular network, leaving fewer pathways through which blood can travel.
Group 4: Pulmonary Artery Obstruction
Chronic thromboembolic pulmonary hypertension, or CTEPH, occurs when old pulmonary emboli fail to dissolve completely. The clots become organized scar tissue that obstructs pulmonary arteries and raises pressure within the lungs.
CTEPH deserves special attention because it may be treatable with surgery or catheter-based procedures. Missing this diagnosis means potentially missing an opportunity for a major improvement or, in selected cases, a cure.
Group 5: Complex or Multifactorial Causes
This group includes conditions in which pulmonary hypertension develops through mechanisms that are not fully understood or involve several processes. Examples may include sarcoidosis, certain blood disorders, metabolic diseases, chronic kidney disease, and some tumors or vascular compression disorders.
Other Pulmonary Vascular Disorders
Not every pulmonary vascular condition fits neatly under chronic pulmonary hypertension. Acute pulmonary embolism can suddenly block blood flow. Pulmonary arteriovenous malformations create abnormal connections between arteries and veins. Pulmonary vasculitis inflames vessel walls, while pulmonary vein stenosis restricts blood returning from the lungs to the heart.
Evidence basis: NHLBI, Pulmonary Hypertension Association, Cleveland Clinic, Merck Manual, and American Thoracic Society.
How Pulmonary Vascular Disease Is Diagnosed
Diagnosis usually requires several steps. An echocardiogram may suggest pulmonary hypertension, but it cannot always confirm the diagnosis or identify the precise cause. Doctors investigate the heart, lungs, blood vessels, oxygen levels, and possible underlying diseases.
Medical History and Physical Examination
The clinician will ask when symptoms began, what activities trigger them, and whether they are worsening. Important details include previous blood clots, autoimmune disease, heart or lung disease, liver disease, sleep apnea, congenital heart defects, medication exposure, pregnancy history, smoking, drug use, and relatives with pulmonary hypertension or unexplained early death.
The examination may include checking oxygen saturation, listening for abnormal heart or lung sounds, inspecting neck veins, and looking for swelling, bluish skin, liver enlargement, or signs of connective tissue disease.
Blood Tests
Blood testing may identify anemia, thyroid disease, liver or kidney problems, HIV infection, autoimmune disorders, and clotting abnormalities. BNP or NT-proBNP testing can provide information about strain on the heart, although these tests are not specific to pulmonary hypertension.
Electrocardiogram and Chest X-Ray
An electrocardiogram may reveal rhythm problems or evidence that the right side of the heart is under stress. A chest X-ray can show enlarged pulmonary arteries, heart enlargement, fluid accumulation, or signs of underlying lung disease.
Echocardiogram
An echocardiogram uses ultrasound to evaluate heart chambers, valves, pumping function, blood flow, and signs of right ventricular strain. It can estimate pulmonary pressure and is commonly used as a screening test. Think of the echocardiogram as the detective who spots suspicious activitynot necessarily the judge delivering the final verdict.
Pulmonary Function and Exercise Tests
Pulmonary function tests measure airflow, lung volume, and gas exchange. A six-minute walk test evaluates functional capacity while tracking heart rate and oxygen saturation. Cardiopulmonary exercise testing may help determine whether exercise limitation is primarily related to the heart, lungs, circulation, or physical conditioning.
CT, MRI, and V/Q Scanning
A chest CT can reveal emphysema, pulmonary fibrosis, enlarged vessels, tumors, or vascular abnormalities. CT pulmonary angiography examines pulmonary arteries for clots and obstructions. Cardiac MRI provides detailed measurements of right ventricular size and performance.
A ventilation-perfusion scan, commonly called a V/Q scan, compares airflow with blood flow in the lungs. It is especially important for screening for chronic thromboembolic disease. Areas receiving air but little blood may indicate blocked pulmonary arteries.
Sleep Study and Genetic Testing
A sleep study may be recommended when sleep apnea or nighttime oxygen loss is suspected. Genetic counseling and testing may be appropriate for selected patients with heritable PAH, a strong family history, or certain rare pulmonary vascular disorders.
Right Heart Catheterization
Right heart catheterization is the gold-standard test for confirming pulmonary hypertension. A thin catheter is guided through a vein into the right side of the heart and pulmonary artery. It directly measures pulmonary artery pressure, right-sided pressure, cardiac output, pulmonary artery wedge pressure, and pulmonary vascular resistance.
These measurements distinguish precapillary disease, postcapillary disease related to left heart pressure, and combined forms. In selected PAH patients, doctors may perform vasoreactivity testing during catheterization to determine whether high-dose calcium channel blockers could be useful.
Evidence basis: American Lung Association, Pulmonary Hypertension Association, Johns Hopkins Medicine, American Thoracic Society, and ACC guidelines.
Treatments for Pulmonary Vascular Disease
Treatment is based on the cause, severity, symptoms, right-heart function, and risk of progression. There is no universal “pulmonary vascular disease pill.” A therapy that relaxes lung arteries may help Group 1 PAH but may not be appropriate for pulmonary hypertension caused by left heart disease.
Treating the Underlying Cause
Group 2 treatment may involve heart-failure medication, blood pressure management, rhythm control, or valve procedures. Group 3 care focuses on the underlying lung disease, supplemental oxygen when needed, treatment of sleep apnea, smoking cessation, and pulmonary rehabilitation.
Acute pulmonary embolism is generally treated with anticoagulation. Patients with severe or unstable embolism may require clot-dissolving medication, catheter-based treatment, mechanical thrombectomy, or surgery.
Targeted Medication for Pulmonary Arterial Hypertension
PAH medications act on biological pathways involved in vessel constriction and abnormal vascular remodeling. Major categories include endothelin receptor antagonists, phosphodiesterase-5 inhibitors, soluble guanylate cyclase stimulators, prostacyclin analogs, and prostacyclin receptor agonists.
Depending on risk, treatment may begin with a combination of drugs rather than one medication. Some therapies are pills, while others are inhaled or continuously delivered through intravenous or under-the-skin pumps.
Sotatercept-csrk is a newer injectable treatment for adults with Group 1 PAH. The FDA approved it to improve exercise capacity and function and reduce the risk of clinical worsening. It does not replace every existing PAH therapy and requires monitoring for potential adverse effects.
Calcium channel blockers are reserved for the small subset of patients who show a favorable response during formal vasoreactivity testing. Trying them without the right testing is not a clever shortcut.
CTEPH Treatment
People with CTEPH generally require long-term anticoagulation to help prevent new clots. Every patient should be evaluated by an experienced CTEPH team to determine whether obstructing material can be removed surgically.
Pulmonary thromboendarterectomy, also called pulmonary endarterectomy, removes chronic scar-like clots from the pulmonary arteries. For eligible patients, it can dramatically lower pulmonary pressure and may be curative.
Balloon pulmonary angioplasty uses a catheter and small balloons to open vessels that cannot be treated surgically or remain narrowed after surgery. Riociguat may be used for inoperable or persistent CTEPH under specialist supervision.
Supportive Treatment
Diuretics can reduce swelling and fluid overload. Supplemental oxygen may help patients with low oxygen levels. Doctors may also recommend reduced sodium intake, carefully supervised exercise, vaccination, smoking cessation, weight monitoring, and management of iron deficiency or abnormal heart rhythms.
Anticoagulation is appropriate for certain conditions but is not automatically prescribed to everyone with pulmonary hypertension. Medication decisions must consider bleeding risk, the PH group, and other medical problems.
Advanced Procedures and Transplantation
Patients with severe disease that progresses despite treatment may be considered for atrial septostomy, lung transplantation, or heart-lung transplantation. These options require evaluation at specialized centers with expertise in pulmonary vascular medicine.
Evidence basis: Mayo Clinic, MedlinePlus, Pulmonary Hypertension Association, FDA, ACC, and UC San Diego Health.
Living With Pulmonary Vascular Disease
Daily management often includes taking medications on schedule, monitoring symptoms, attending follow-up appointments, and reporting changes early. A sudden increase in weight, swelling, breathlessness, fainting, or reduced activity tolerance may signal worsening right-heart function or fluid retention.
Exercise can be beneficial when the condition is stable and the program is approved by the treating team. Supervised pulmonary or cardiac rehabilitation may improve endurance and confidence. Heavy lifting and highly strenuous activity may be unsafe for some patients, especially when it causes dizziness, chest pain, or faintness.
Patients should discuss pregnancy, air travel, altitude exposure, planned surgery, over-the-counter decongestants, supplements, and new prescriptions with their specialist. Several PAH medications can harm a developing fetus, and abruptly stopping advanced therapy can be dangerous.
Conclusion
Pulmonary vascular disease is not one diagnosis but a collection of conditions affecting blood flow through the lungs. Symptoms such as progressive breathlessness, fatigue, chest discomfort, fainting, palpitations, and swelling deserve medical attention, particularly when they worsen during activity.
Accurate classification is the key to effective care. Echocardiography can raise suspicion, but right heart catheterization often provides the measurements needed to confirm pulmonary hypertension. Additional imaging, lung testing, blood work, and clot evaluation help identify the underlying cause.
Modern treatment ranges from managing heart or lung disease to advanced PAH medications, anticoagulation, pulmonary endarterectomy, balloon pulmonary angioplasty, and transplantation. Earlier recognition gives clinicians more opportunities to protect the right side of the heart and preserve quality of life.
The Patient Experience: What the Journey Often Feels Like
The following is a generalized composite scenario based on common clinical experiences. It does not describe a specific patient.
The first sign may be so ordinary that it barely earns a second thought. A person who previously climbed two flights of stairs without stopping begins pausing halfway. They blame a busy schedule, poor sleep, aging, weight gain, or a mysterious shortage of motivation. For a while, resting solves the problem.
Over the next several months, the breathlessness becomes harder to ignore. Carrying groceries feels like exercise. Walking quickly while talking becomes uncomfortable. Friends may not notice because the person quietly adjustsparking closer, taking elevators, declining hikes, and arriving early enough to catch their breath before anyone sees.
The first medical visit may produce several reasonable possibilities. Asthma, anemia, infection, thyroid disease, anxiety, and physical deconditioning can all cause similar symptoms. Initial blood work or a chest X-ray may be normal or only mildly abnormal. A trial inhaler might not help much, which can be frustrating for both patient and clinician.
Eventually, an echocardiogram shows signs that the right side of the heart is working harder than expected. That result can create two competing emotions: worry because something is wrong, and relief because the symptoms finally have objective evidence. The patient is referred to a pulmonologist, cardiologist, or pulmonary hypertension center.
The specialist visit is often detailed. Questions cover old blood clots, sleep habits, autoimmune symptoms, liver disease, medications, drug exposure, family history, and past heart problems. The patient may undergo lung function tests, a CT scan, a V/Q scan, a six-minute walk, and more blood tests. It can feel like the body has become a group project involving half the hospital.
Right heart catheterization may sound intimidating. In practice, patients are usually given local anesthetic and medication for comfort while a catheter is inserted through a vein. The procedure provides the pressure and blood-flow measurements that noninvasive tests cannot reliably supply. For many people, the results finally explain why daily activity has become so difficult.
Starting treatment brings another adjustment period. A person may need several medications with different schedules, laboratory monitoring, oxygen, dietary changes, or a portable infusion pump. Side effects and insurance approvals can add stress. Improvement may also be gradual rather than cinematic; there is rarely a dramatic movie scene in which someone takes one pill and immediately jogs into the sunset.
Progress is often measured in practical victories: walking farther during a six-minute test, showering without sitting down, sleeping more comfortably, returning to work, or enjoying an outing without mapping every nearby chair. Follow-up testing helps the care team decide whether treatment should be continued, adjusted, or intensified.
Emotional support matters as much as logistics. Breathlessness can be frightening, and an uncommon diagnosis may feel isolating. Support groups, counseling, pulmonary rehabilitation, and clear communication with clinicians can help patients regain a sense of control.
The most valuable habit is often careful observation. Tracking activity tolerance, swelling, oxygen readings when recommended, and daily weight can reveal changes before they become emergencies. Patients who understand their diagnosis and treatment plan are better prepared to ask useful questions, recognize warning signs, and participate in decisions about their care.
Experience section informed by diagnostic and care pathways described by the American Lung Association, Pulmonary Hypertension Association, Johns Hopkins Medicine, and UC San Diego Health.
Note: This article is for general education and does not replace diagnosis or treatment from a qualified healthcare professional. Call 911 for sudden severe breathing difficulty, chest pain, fainting, coughing up blood, blue or gray skin, confusion, or other potentially life-threatening symptoms.
